(Q45076118)

English

Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost-identification analysis of concomitant and adjuvant treatment with temozolomide until patient death

scientific article published in November 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost-identification analysis of concomitant and adjuvant treatment with temozolomide until patient death (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Jean-Blaise Wasserfallen

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sandrine Ostermann

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Alessia Pica

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

René-Olivier Mirimanoff

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Serge Leyvraz

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Jean-Guy Villemure

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Roger Stupp

7

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

language of work or name

0 references

publication date

1 November 2004

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

101

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

2098-2105

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

21 January 2018

Cost and health implications of cholesterol lowering

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

21 January 2018

Measuring health-related quality of life

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

21 January 2018

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Stud

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

7 January 2021

based on heuristic

inferred from DOI database lookup

Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

7 January 2021

based on heuristic

inferred from DOI database lookup

Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

7 January 2021

based on heuristic

inferred from DOI database lookup

Post hoc economic analysis of temozolomide versus dacarbazine in the treatment of advanced metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

7 January 2021

based on heuristic

inferred from DOI database lookup

Can Karnofsky performance status be transformed to the Eastern Cooperative Oncology Group scoring scale and vice versa?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

7 January 2021

based on heuristic

inferred from DOI database lookup

Patient preferences for oral versus intravenous palliative chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

7 January 2021

based on heuristic

inferred from DOI database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

7 January 2021

based on heuristic

inferred from DOI database lookup

The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

7 January 2021

based on heuristic

inferred from DOI database lookup

High-grade astrocytomas: resource use, clinical outcomes, and cost of care

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

7 January 2021

based on heuristic

inferred from DOI database lookup

The costs of managing patients with malignant glioma at a neuro-oncology clinic.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20619

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.20619

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45076118&oldid=2064602562"